Connect with us
The creation of the clinical trials unit arose to enhance and support all clinical research carried out within the framework of an early phase clinical trial...
Werfen is chaired by Marc Rubiralta and in 2022 it achieved a turnover of 1.84 billion. In the largest operation in its history, the group closed...
The biotech sector is composed of 66 percent micro-enterprises, consisting of one to nine employees, and only 8 percent large structures, with more than 250 people....
Mediktor, based in the Recinto Modernista de Sant Pau in Barcelona, operates a B2B model and offers software as a service (SaaS) for insurance companies, hospitals,...
Microviable Therapeutics emerged as a spin-off of Ipla-Csic in 2016, focused on the development of therapeutic technologies and products derived from microbiota. Technological development, together with the...
In recent years, Grifols has invested in its innovation infrastructure and currently has more than 1,200 people who work together in four global research centers. In 2021,...
Currently, Cebiotex maintains a strategic alliance with the Catalan pharmaceutical company Prasfarma, a supplier of cell membranes. The biotechnology company uses the facilities of the pharmaceutical company...
The current round has an investment commitment of up to €3 million, which includes the participation of the founding partners. The €7 million will make it...
Following various acquisitions, Bruker moved its headquarters to Billerica/Massachusetts (Greater Boston) several years ago. In 2022, more than 7,500 Bruker employees worldwide generated sales of just...
During this first half of the year, Switzerland has fallen as the leading supplier of Spanish pharmaceuticals, giving way to the United States in first position, with...
 |
|
 |  |
 |
|